A deterioration of the gut–blood barrier enhances permeability, enabling microorganisms, SCFAs, and bacterial toxins such as LPS to dissolve into the bloodstream and activate toll-like receptors 4 (TLR4) on the immunity cells, leading to chronic inflammation and insulin resistance. Here, TLR4 is linked to Insulin resistance.